Hale Therapeutics Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
16
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$54.7K
- Investors
-
29
Hale Therapeutics General Information
Description
Developer of a vaporizer system designed to help people battling tobacco addiction. The company's system is designed with a comfortable mouthpiece, two-sided grips for comfort, a light-emitting diode indicator for battery life, and companion applications to track usage and wean off the substance to reduce withdrawal symptoms, enabling users to easily reduce their nicotine intake.
Contact Information
Website
www.tryhale.comCorporate Office
- 2025 Washington Avenue
- Suite 216
- Philadelphia, PA 19146
- United States
Corporate Office
- 2025 Washington Avenue
- Suite 216
- Philadelphia, PA 19146
- United States
Hale Therapeutics Timeline
Hale Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 12. Grant | 09-Jan-2023 | $54.7K | Completed | Generating Revenue | ||
| 11. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 10. Equity Crowdfunding | 13-Jul-2022 | Completed | Generating Revenue | |||
| 9. Accelerator/Incubator | 06-Dec-2021 | Completed | Generating Revenue | |||
| 8. Early Stage VC | 10-Nov-2021 | Completed | Generating Revenue | |||
| 7. Accelerator/Incubator | 04-Nov-2021 | Completed | Generating Revenue | |||
| 6. Early Stage VC (Series 1) | 01-Dec-2020 | Completed | Generating Revenue | |||
| 5. Grant | 24-Jun-2020 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 13-Nov-2019 | $1.7M | $2.33M | Completed | Generating Revenue | |
| 3. Accelerator/Incubator | 01-Apr-2019 | $500K | $625K | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Hale Therapeutics Comparisons
Industry
Financing
Details
Hale Therapeutics Competitors (5)
One of Hale Therapeutics’s 5 competitors is Pelago, a Venture Capital-Backed company based in New York, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Pelago | Venture Capital-Backed | New York, NY | ||||
| Lucy (Food Products) | Venture Capital-Backed | Las Vegas, NV | ||||
| Glaxosmithkline Consumer Healthcare | Corporate Backed or Acquired | Gurugram, India | ||||
| Pfizer (Pharmaceuticals) | Corporation | New York, NY | ||||
| Johnson & Johnson | Corporation | New Brunswick, NJ |
Hale Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Hale Therapeutics Patents
Hale Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230172280-A1 | Vaporization device | Pending | 07-Dec-2021 | ||
| US-20200229512-A1 | Vaporization device | Inactive | 18-Jan-2019 | ||
| GB-2595107-A | Vaporization device | Active | 18-Jan-2019 | ||
| GB-202111012-D0 | Vaporization device | Active | 18-Jan-2019 | ||
| US-20200229508-A1 | Vaporization device | Active | 18-Jan-2019 | A24F40/50 |
Hale Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Hale Therapeutics Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| AlphaLab Health | Accelerator/Incubator | Minority | ||
| Atland Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Feldsmith Capital | Venture Capital | Minority |
Hale Therapeutics FAQs
-
When was Hale Therapeutics founded?
Hale Therapeutics was founded in 2017.
-
Where is Hale Therapeutics headquartered?
Hale Therapeutics is headquartered in Philadelphia, PA.
-
What is the size of Hale Therapeutics?
Hale Therapeutics has 16 total employees.
-
What industry is Hale Therapeutics in?
Hale Therapeutics’s primary industry is Therapeutic Devices.
-
Is Hale Therapeutics a private or public company?
Hale Therapeutics is a Private company.
-
What is Hale Therapeutics’s current revenue?
The current revenue for Hale Therapeutics is .
-
How much funding has Hale Therapeutics raised over time?
Hale Therapeutics has raised $2.35M.
-
Who are Hale Therapeutics’s investors?
National Institutes of Health, AlphaLab Health, Atland Ventures, , and Feldsmith Capital are 5 of 29 investors who have invested in Hale Therapeutics.
-
Who are Hale Therapeutics’s competitors?
Pelago, Lucy (Food Products), Glaxosmithkline Consumer Healthcare, Pfizer (Pharmaceuticals), and Johnson & Johnson are competitors of Hale Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
